Alexandria Real Estate Equities Secures Landmark Lease for Life Science Research Facility
- Alexandria Real Estate Equities secured a landmark 16-year lease for a custom-built research facility in San Diego.
- The lease, covering 466,598 square feet, is the largest in Alexandria's 31-year history, enhancing its life sciences portfolio.
- Alexandria's commitment to collaborative spaces reinforces its role in advancing life science research and maintaining high occupancy rates.
Alexandria Real Estate Equities Secures Major Lease to Enhance Life Science Collaboration
In a landmark achievement, Alexandria Real Estate Equities, Inc. announces a pivotal 16-year lease agreement with a prominent multinational pharmaceutical company for a custom-built research facility at its Campus Point by Alexandria Megacampus in San Diego. This deal, which encompasses 466,598 rentable square feet, marks the largest life science lease in the company’s 31-year history. It underscores Alexandria’s commitment to developing state-of-the-art environments tailored to the rapidly evolving needs of the life sciences sector. The new research hub is set to play a crucial role in fostering innovation and collaboration among industry professionals, further solidifying Campus Point's status as a centerpiece of Alexandria's Megacampus strategy.
Daniel J. Ryan, co-president and San Diego regional market director, highlights the strategic importance of the Campus Point site, which is home to approximately 3,000 professionals engaged in the development of life-changing medicines. This new facility not only expands the physical footprint of Alexandria but also enhances the collaborative ecosystem that the company has meticulously cultivated since its inception in 1994. Alexandria’s focus on creating environments that facilitate partnerships and innovation reflects its dedication to supporting the life sciences community and driving advancements in medical research.
The Campus Point area stands out as a vibrant hub for life sciences, with Alexandria's portfolio boasting an impressive occupancy rate of 98.8% as of June 30, 2025. This high occupancy rate indicates robust demand for quality life science spaces, reinforcing Alexandria's reputation as a leading provider in the sector. By continually investing in the development of collaborative spaces, Alexandria Real Estate Equities not only strengthens its tenant relationships but also ensures sustainable long-term cash flow, positioning itself as a key player in the life sciences real estate market.
In addition to securing this major lease, Alexandria continues to focus on enhancing tenant experiences and fostering innovation within its properties. This commitment not only attracts high-profile tenants but also contributes to the overall growth of the life sciences industry. With the successful execution of this lease, Alexandria reinforces its role as a vital contributor to the advancement of life science research and development.
The company’s strategic initiatives and focus on collaboration within its ecosystems highlight Alexandria’s forward-thinking approach in a competitive market. As the life sciences sector continues to expand, Alexandria Real Estate Equities remains poised to adapt and thrive, ensuring that it meets the evolving needs of its tenants and supports groundbreaking advancements in medicine.
